TxCell Receives US Patent For Ovasave To Treat IBD
IBD News, News
A key patent was recently granted by the United States Patent and Trademark Office (USPTO) to TxCell SA for its lead product Ovasave® to address inflammatory bowel disease (IBD). The patent will protect Ovasave until 2030. TxCell SA ... Read more